TB-IGRA

Successfully obtained in the EU CE access certification

Passed ISO13485 certification

Mycobacterium tuberculosis can invade all tissues and organs of the body, but lung infection is the most common. The clinical symptoms are mainly long-term cough, sputum, hemoptysis, chest pain, dyspnea, low or high fever, fatigue, weakness, weight loss, night sweats, etc. At present, the clinical diagnosis of tuberculosis pathogens mainly adopts mycobacterial acid-fast smear staining, culture and molecular diagnosis methods.

《GLOBAL TUBERCULOSIS REPORT 2020》

   - Global new cases of tuberculosis in 2017 was  

      889000

   - The most serious are males

   - The death toll is 39000

   - Tuberculosis is the killer of people living with HIV

Product advantage

Operation steps

Clinical significance: 

• Auxiliary diagnosis of tuberculosis 

• Auxiliary diagnosis of extra-pulmonary tuberculosis 

• Screening of latent tuberculosis for high-risk groups (biological agents/immunosuppressants, HIV patients, hemodialysis, organ transplant patients, etc.)

Applicable departments: 

Tuberculosis/respiratory department, infectious/infectious department, rheumatology department, gastroenterology department, pediatrics, reproductive center